Crossref
2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency
The Brown University Child & Adolescent Psychopharmacology Update · 2026-04 · 28 (4) · 7-7
DOI: 10.1002/cpu.31055 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Brown University Child & Adolescent Psychopharmacology Update, online erschienen am 23.03.2026. Verfasst von Alison Knopf.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Knopf, A. (2026). 2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency. The Brown University Child & Adolescent Psychopharmacology Update, 28(4), 7-7. https://doi.org/10.1002/cpu.31055
Vancouver
Knopf A. 2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency. The Brown University Child & Adolescent Psychopharmacology Update. 2026;28(4):7-7. doi:10.1002/cpu.31055
BibTeX
@article{Knopf2026,
author = {Knopf, Alison},
title = {2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency},
journal = {The Brown University Child & Adolescent Psychopharmacology Update},
year = {2026},
volume = {28},
number = {4},
pages = {7--7},
doi = {10.1002/cpu.31055}
}
EUVIMED